Entera Bio's total assets for Q3 2025 were $17.41M, a decrease of -11.49% from the previous quarter. ENTX total liabilities were $2.17M for the fiscal quarter, a -9.87% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.